FMR LLC and Abigail P. Johnson filed an amended Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of 6,239,237 shares of Odyssey Therapeutics Inc. common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: FMR LLC and Abigail P. Johnson each reported beneficial ownership of 6,239,237 shares of Odyssey Therapeutics Inc. common stock.
  • Percent of class: The reported holdings represent 13.0% of the outstanding common stock, according to the filing.
  • Sole voting power (FMR LLC): FMR LLC reported sole voting power over 6,239,231 shares, with 0 shares subject to shared voting power.
  • Sole dispositive power: Both FMR LLC and Abigail P. Johnson each reported sole dispositive power over 6,239,237 shares, with no shared dispositive power.
  • Fidelity Growth Company Commingled Pool: The filing identified this entity as holding 2,892,724 shares, representing 6.0% of the total outstanding common stock as of September 30, 2026.
  • Event date: The date of the event requiring the filing was September 30, 2026.

FMR LLC and Abigail P. Johnson Disclose 6,239,237 Shares in Odyssey Therapeutics

According to the amended Schedule 13G filed on November 4, 2026, FMR LLC, a Delaware-organized holding company, and Abigail P. Johnson, a United States citizen, each reported aggregate beneficial ownership of 6,239,237 shares of common stock in Odyssey Therapeutics Inc. (CUSIP: 67613T104). The filing identifies both as separate reporting persons, with FMR LLC classified as a parent holding company and Abigail P. Johnson classified as an individual.

The filing disclosed that FMR LLC holds sole voting power over 6,239,231 shares and sole dispositive power over 6,239,237 shares. Abigail P. Johnson reported sole dispositive power over the same 6,239,237 shares but no sole or shared voting power. Neither reporting person reported any shared voting or shared dispositive power. The filing noted that one or more other persons are known to have the right to receive or direct the receipt of dividends or sale proceeds from the common stock, specifically identifying Fidelity Growth Company Commingled Pool as holding 2,892,724 shares, equal to 6.0% of the total outstanding common stock at September 30, 2026.

The filing was signed by Stephanie J. Brown on behalf of both FMR LLC and Abigail P. Johnson under separate powers of attorney. FMR LLC's principal business office is located at 245 Summer Street, Boston, Massachusetts 02210. Odyssey Therapeutics Inc.'s principal executive offices are listed as 51 Sleeper Street, Boston, MA 02210. The filing states that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

What Was Disclosed

FMR LLC and Abigail P. Johnson filed an amended Schedule 13G disclosing combined beneficial ownership of 6,239,237 shares, or 13.0%, of Odyssey Therapeutics Inc. common stock as of September 30, 2026, with FMR LLC acting as the parent holding company.